| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 90999 |
|
15,077 |
753 |
$696K |
| Q4081 |
Injection, epoetin alfa, 100 units (for esrd on dialysis) |
20,808 |
734 |
$33K |
| A4657 |
Syringe, with or without needle, each |
2,501 |
741 |
$12K |
| J1756 |
Injection, iron sucrose, 1 mg |
2,597 |
509 |
$3K |
| J1270 |
Injection, doxercalciferol, 1 mcg |
12,160 |
672 |
$2K |
| G0499 |
Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result |
127 |
43 |
$99.49 |
| 83970 |
|
442 |
216 |
$56.25 |
| 82728 |
|
496 |
252 |
$33.91 |
| 83550 |
|
465 |
235 |
$21.41 |
| 83540 |
|
464 |
234 |
$16.18 |
| 85048 |
|
912 |
478 |
$13.03 |
| 85041 |
|
915 |
478 |
$11.98 |